CADL ▼ -2.2% - Candel Therapeutics, Inc. $CADL - Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Candel Therapeutics announced inducement grants to employees under Nasdaq rules, a routine equity compensation action that typically has minimal direct market impact. The 2.2% decline appears unrelated to the grant announcement itself and may reflect broader market conditions or investor sentiment toward the biotech sector. 01-SEP-2026 04:05 PM ET